Item 5.07 Submission of Matters to a Vote of Security Holders

On June 9, 2020, Endologix, Inc. (the "Company") held its 2020 Annual Meeting of Stockholders (the "Annual Meeting"), at which a total of 15,777,285 shares of the Company's common stock, or approximately 83% of the shares entitled to vote, were represented in person or by valid proxies. A description of each matter voted upon at the Annual Meeting is described in detail in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 27, 2020. Set forth below are final voting results for the proposals that were subject to a vote of the Company's stockholders at the Annual Meeting.



1.  For the proposal to elect two nominees for director to serve a three-year
    term expiring at the Company's 2023 Annual Meeting of Stockholders, the
    voting results were as follows:



Name of Directors Elected    For    Withheld  Broker Non-Votes
Daniel Lemaitre           5,802,844 2,401,406    7,573,035
Jane Kiernan              7,469,962  734,288     7,573,035

The following individuals are continuing directors with terms expiring at the Company's 2021 Annual Meeting of Stockholders: Thomas C. Wilder, III and John Onopchenko.

The following individuals are continuing directors with terms expiring at the Company's 2022 Annual Meeting of Stockholders: Gregory D. Waller and Thomas F. Zenty, III.

2. For the proposal to approve, on a non-binding advisory basis, the


    compensation of the Company's named executive officers, the voting results
    were as follows:



   For     Against  Abstain Broker Non-Votes
2,569,734 5,566,853 67,663     7,573,035

3. For the proposal to ratify KPMG LLP as the Company's independent registered


    public accounting firm for the fiscal year ending December 31, 2020, the
    voting results were as follows:



   For     Against Abstain
15,482,670 142,672 151,943

4. For the proposal to approve the amendment to the Endologix, Inc. Amended and


    Restated 2015 Stock Incentive Plan, as amended, to increase the numbers of
    shares of the Company's common stock reserved for issuance under the plan by
    1,000,000 shares, or from 4,130,000 shares to 5,130,000 shares, the voting
    results were as follows:



   For     Against  Abstain Broker Non-Votes
5,703,248 2,425,789 75,213     7,573,035



No other matters were presented for stockholder approval at the Annual Meeting.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses